11/00054.11/2026 - Aquisição de SELPERCAtinib 80 mg Cáps (AUE_202501707)

ID 13130383 · Portal BASE
Price
Base Price
€147,456,136,800 .00
Effective Price
€147,456 .00 -100.0%
Contract Details
Contract Type
Aquisição de bens móveis
Procedure
Ajuste Direto Regime Geral
CPV Code
33600000
Location
Portugal, Aveiro, Santa Maria da Feira
Bidder Count
—
Winner
LILLY-PORTUGAL PRODUTOS FARMACÊUTICOS LDA
NIF 500165602
Company
Dates
Publication
04 Feb 2026
Celebration
11 Dec 2025
Contracting Entity
Centro Hospitalar de Entre o Douro e Vouga, EPE
NIF 508878462
Public body
Data Source
Portal BASE
Api · synced 2026-04-17
Risk Flags
Score 105 · HIGH RISK
B5 · Benford's Law Deviation
B5_BENFORD_DEVIATION
HIGH
Chi2
88.3634
Sample size
7169
Observed
{"1"=>2416, "2"=>1290, "3"=>731, "4"=>596, "5"=>509, "6"=>478, "7"=>429, "8"=>350, "9"=>370}
Rule
B5 Benford's Law deviation: chi-square 88.3634 (df=8, n=7169, threshold=15.507)
Detected 2026-03-06
A2 · Late Publication
A2_PUBLICATION_AFTER_CELEBRATION
HIGH
Publication Date
04 Feb 2026
Signing Date
11 Dec 2025
Days Late
55
Rule
A2/A3 late publication: 55 days after signing (threshold: 10)
Detected 2026-03-06
A9 · Abnormal Price Reduction
A9_PRICE_REDUCTION
LOW
Base price
147456136800.0
Total effective price
147456.0
Ratio
0.0
Direction
reduction
Rule
A9 price reduction: ratio 0.0 outside [0.5, 1.5]
Detected 2026-03-06